27-03-2024
Some of the biggest clothing and department-store chains rely on their own private-label credit cards to cushion their bottom lines.
27-03-2024
U.S.-listed shares of Nio Inc. on Wednesday hovered around a 52-week low after the Chinese electric-vehicle maker cut its current-quarter sales estimates.
27-03-2024
GameStop Corp., which reported a significant sales decline its fourth-quarter results late Tuesday, could meet its demise before the end of this decade, according to analyst firm Wedbush.
27-03-2024
Investors have been bidding up the stock partly on speculation that its asset cap imposed by the Federal Reserve may be lifted in the next year or so.
27-03-2024
Trump Media & Technology Group’s stock surged Wednesday, but a sharp late-day pullback in the previous session may have acted as a warning to investors not to assume a smooth ride higher.
27-03-2024
Carnival Corp.’s stock dropped Wednesday after the cruise operator reported an narrower-than-expected fiscal first-quarter loss but also provided an estimate for what the collapse of the Francis Scott Key Bridge in Baltimore would cost it this year.
27-03-2024
Momentum stocks are coming off their best stretch of outperformance in years — since just before the financial crisis, in fact. That’s making some investors nervous.
27-03-2024
Data from a Phase 1 trial is the latest bullish news from the biotech that may offer cheap entry to weight-loss mania.
27-03-2024
Easter sales will total $22.4 billion in 2024, according to the National Retail Federation — a 7% decline from last year.
27-03-2024
U.S. banks are struggling to keep up with evolving artificial-intelligence technology that has enabled fraudsters to easily impersonate customers and spread malware using AI-generated text, according to a report published Wednesday by the Treasury Department.
27-03-2024
Higher office space vacancies trigger rise in criticized and modified loans, as a maturity wall looms
27-03-2024
Merck’s stock rallied into record territory Wednesday, after the drug giant’s treatment for pulmonary arterial hypertension, Winrevair, was approved by the U.S. Food and Drug Administration.